Q: What made healthcare a compelling vertical for Nabla, as opposed to building something more broadly applicable across industries?
A: Healthcare was a deliberate choice from day one. We saw an opportunity to apply large language models to one of the most meaningful and underserved use cases. Clinicians spend up to 40 percent of their time on documentation, often outside of patient hours. That administrative burden directly impacts both clinician well-being and patient experience. Generative AI offered a clear path to change that. This focus has proven to be well timed. Healthcare is now one of the fastest growing and highest impact verticals for AI, with ambient clinical documentation having emerged as a leading use case due to its immediate ROI and measurable impact on burnout, efficiency, and care quality.
Q: What does it actually take to build something that clinicians will genuinely adopt and use?
A: Healthcare is one of the most challenging industries to build in, and healthcare users are among the most demanding in any industry. It is often said that there is a “graveyard” of companies that underestimated its complexity. The stakes are fundamentally different. This is not about productivity gains alone. It is about patient safety, clinical accuracy, and trust. For an ambient AI assistant to be truly useful, clinicians need near-perfect accuracy… even small errors can have clinical consequences. Notes must be ready immediately after the visit. And the product must integrate seamlessly into existing systems, especially EHRs. Clinicians cannot afford to switch between tools or disrupt their workflow. On top of that, the experience has to be intuitive, fast, and invisible. Ambient AI must feel like a natural extension of the clinical workflow, not another system to manage. If clinicians need to spend time correcting outputs, the value disappears. Ultimately, clinicians are not looking for a generic AI tool. They need an assistant that fits into clinical workflows and meets the standards of patient care. The bar is high.
Q: How did your go-to-market strategy evolve as you scaled?
A: Nabla initially grew through a product-led approach, offering freemium access to clinicians. This allowed us to observe real-world usage at scale and rapidly iterate based on feedback. That grassroots adoption led to strong word-of-mouth, with clinicians introducing Nabla into their organizations. Over time, this translated into inbound interest from major health systems, including Children’s Hospital Los Angeles, The University of Iowa Health Care, CVS Health, Denver Health, and Carle Health. But building in healthcare requires earning trust at every level. That requires consistently high-quality outputs across diverse scenarios, from primary care to highly specialized fields.
Q: As you look ahead, how do you think about growth? Does it come from going deeper within healthcare, or expanding into adjacent areas?
A: The space is vast, and it is easy to try to solve too many problems at once. Nabla made a deliberate decision to focus on one of the most urgent and universal pain points: clinical documentation burden and the burnout it creates. That focus is what allowed us to build something clinicians genuinely rely on. But that’s just the starting point. We are evolving from ambient documentation into contextual clinical intelligence, operating at the center of every patient encounter to unify documentation, coding, and workflow execution into a single intelligent system. The goal is to support clinicians seamlessly before, during, and after care is delivered. We’re building towards a platform that can reason, assist, and safely execute tasks within clinical workflows, enabling health systems to move beyond fragmented tools toward scalable, system-wide impact.